Hirofumi Fujii scite author profile

Hirofumi Fujii

5Publications

2,558Citation Statements Received

6Citation Statements Given

How they've been cited

How they cite others

Affiliations

National Cancer Center Hospital East, Jichi Medical University

Publications

Order By: Most citations

Observation of Cabibbo SuppressedB→D()K−
Abe¹,
Adachi²,
Ahn³
et al. 2001
Phys. Rev. Lett.*
523
64
903
6
View full text Add to dashboard Cite

We report observations of the Cabibbo suppressed decays B-->D((*))K- using a 10.4 fb(-1) data sample accumulated at the Upsilon(4S) resonance with the Belle detector at the KEKB e(+)e(-) storage ring. We find that the ratios of Cabibbo suppressed to Cabibbo favored branching fractions are B(B--->D0K-)/B(B--->D0pi(-)) = 0.079+/-0.009+/-0.006, B(B(0)-->D+K-)/B(B(0)-->D+pi(-)) = 0.068+/-0.015+/-0.007, B(B--->D(*0)K-)/B(B--->D(*0)pi(-)) = 0.078+/-0.019+/-0.009, and B(B(0)-->D(*+)K-)/B(B(0)-->D(*+)pi(-)) = 0.074+/-0.015+/-0.006. These are the first observations of the B-->D+K-, D(*0)K-, and D(*+)K- decay processes.

show abstract

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study

Swain¹,

Miles²,

Kim³

et al. 2020

The Lancet Oncology

593

393

View full text Add to dashboard Cite

Phase III study comparing oxaliplatin plus S-1 with cisplatin plus S-1 in chemotherapy-naïve patients with advanced gastric cancer

et al. 2015

View full text Add to dashboard Cite

show abstract

The Belle detector

Abashian

Gotow

Morgan

et al. 2002

Nuclear Instruments and Methods in Physics Research Section A:

1,377

383

View full text Add to dashboard Cite

The Physics of the B Factories

et al. 2014

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Hirofumi Fujii

Observation of Cabibbo SuppressedB→D()K−
Abe¹,
Adachi²,
Ahn³
et al. 2001
Phys. Rev. Lett.*
523
64
903
6
View full text Add to dashboard Cite

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study

Phase III study comparing oxaliplatin plus S-1 with cisplatin plus S-1 in chemotherapy-naïve patients with advanced gastric cancer

The Belle detector

The Physics of the B Factories

Contact Info

Product

Resources

About

Hirofumi Fujii

Observation of Cabibbo SuppressedB→D(*)K−Abe1, Adachi2, Ahn3 et al. 2001Phys. Rev. Lett.523649036View full textAdd to dashboardCite

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study

Phase III study comparing oxaliplatin plus S-1 with cisplatin plus S-1 in chemotherapy-naïve patients with advanced gastric cancer

The Belle detector

The Physics of the B Factories

Contact Info

Product

Resources

About

Observation of Cabibbo SuppressedB→D()K−
Abe¹,
Adachi²,
Ahn³
et al. 2001
Phys. Rev. Lett.*
523
64
903
6
View full text Add to dashboard Cite